Ignite Creation Date:
2024-05-06 @ 7:30 PM
Last Modification Date:
2024-10-26 @ 3:08 PM
Study NCT ID:
NCT06032442
Status:
COMPLETED
Last Update Posted:
2023-09-13
First Post:
2023-09-04
Brief Title:
A Study to Assess Efficacy of Supporting Properties and Safety of ARTNEO in Patients With Knee Osteoarthritis
Sponsor:
NPO Petrovax
Organization:
NPO Petrovax
Study Overview
Official Title:
An Open Randomized Prospective Study of the Supporting Properties of the Dietary Supplement ARTNEO in Comparison With Active Control in Parallel Groups in Patients With Knee Osteoarthritis Aged 40 to 75 Years
Status:
COMPLETED
Status Verified Date:
2023-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of the interventional study is to assess the effectiveness of the supporting properties and safety of the dietary supplement ARTNEO ARTNEO capsules with an average weight of 585 mg in patients with osteoarthritis of the knee joint of both sexes aged 40 to 75 years The main questions it aims to answer are
1 To evaluate the effectiveness of the supporting properties of dietary supplement ARTNEO ARTNEO in patients with knee osteoarthritis in comparison with active control
2 To evaluate the safety of the dietary supplement ARTNEO ARTNEO in patients with knee osteoarthritis
1 To evaluate the effectiveness of the supporting properties of dietary supplement ARTNEO ARTNEO in patients with knee osteoarthritis in comparison with active control
2 To evaluate the safety of the dietary supplement ARTNEO ARTNEO in patients with knee osteoarthritis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None